IDEXX LABORATORIES INC /DE Shareholders' Equity
IDEXX LABORATORIES INC /DE (IDXX) had Shareholders' Equity of $1.61 billion as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-04
- 2026-06-30: Stockholders' Equity Attributable to Parent $1.61B.
- 2026-03-31: Stockholders' Equity Attributable to Parent $1.56B.
- 2025-12-31: Stockholders' Equity Attributable to Parent $1.61B.
- 2025-09-30: Stockholders' Equity Attributable to Parent $1.56B.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $1.61B 10-Q · filed 2026-08-04 |
| 2026-03-31 | $1.56B 10-Q · filed 2026-08-04 |
| 2025-12-31 | $1.61B 10-Q · filed 2026-08-04 |
| 2025-09-30 | $1.56B 10-Q · filed 2025-11-03 |
| 2025-06-30 | $1.46B 10-Q · filed 2026-08-04 |
| 2025-03-31 | $1.45B 10-Q · filed 2026-08-04 |
| 2024-12-31 | $1.60B 10-Q · filed 2026-08-04 |
| 2024-09-30 | $1.62B 10-Q · filed 2025-11-03 |
| 2024-06-30 | $1.58B 10-Q · filed 2025-11-03 |
| 2024-03-31 | $1.57B 10-Q · filed 2025-11-03 |
| 2023-12-31 | $1.48B 10-K · filed 2026-02-20 |
| 2023-09-30 | $1.30B 10-Q · filed 2024-10-31 |
| 2023-06-30 | $1.09B 10-Q · filed 2024-10-31 |
| 2023-03-31 | $841.10M 10-Q · filed 2024-10-31 |
| 2022-12-31 | $608.74M 10-K · filed 2026-02-20 |
| 2022-09-30 | $476.00M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $457.01M 10-Q · filed 2023-11-01 |
| 2022-03-31 | $639.80M 10-Q · filed 2023-11-01 |
| 2021-12-31 | $689.99M 10-K · filed 2025-02-21 |
| 2021-09-30 | $754.75M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $747.46M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $702.70M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $632.09M 10-K · filed 2022-02-16 |
| 2020-09-30 | $440.58M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $272.96M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $107.67M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $177.47M 10-K · filed 2021-02-12 |
| 2019-09-30 | $202.42M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $171.25M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $51.56M 10-Q · filed 2019-05-01 |
| 2018-12-31 | -$9.51M 10-K · filed 2020-02-14 |
| 2018-09-30 | -$1.60M 10-Q · filed 2018-11-01 |
| 2018-06-30 | -$41.13M 10-Q · filed 2018-08-01 |
| 2018-03-31 | -$49.27M 10-Q · filed 2018-05-04 |
| 2017-12-31 | -$54.11M 10-K · filed 2019-02-15 |
| 2017-09-30 | -$48.62M 10-Q · filed 2017-10-31 |
| 2017-06-30 | -$86.33M 10-Q · filed 2017-08-01 |
| 2017-03-31 | -$74.09M 10-Q · filed 2017-04-28 |
| 2016-12-31 | -$108.35M 10-K · filed 2018-02-16 |
| 2016-09-30 | $54.85M 10-Q · filed 2016-11-01 |
| 2016-06-30 | -$8.64M 10-Q · filed 2016-08-02 |
| 2016-03-31 | -$73.92M 10-Q · filed 2016-04-29 |
| 2015-12-31 | -$84.13M 10-K · filed 2017-02-17 |
| 2015-09-30 | -$38.89M 10-Q · filed 2015-10-28 |
| 2015-06-30 | $8.47M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $34.02M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $117.52M 10-K · filed 2016-02-17 |
| 2014-09-30 | $229.39M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $452.87M 10-Q · filed 2014-07-25 |
| 2014-03-31 | $512.22M 10-Q · filed 2014-04-25 |
| 2013-12-31 | $518.19M 10-K · filed 2015-02-17 |
| 2013-09-30 | $534.85M 10-Q · filed 2013-10-22 |
| 2013-06-30 | $549.55M 10-Q · filed 2013-07-23 |
| 2013-03-31 | $631.25M 10-Q · filed 2013-04-23 |
| 2012-12-31 | $636.22M 10-K · filed 2014-02-18 |
| 2012-09-30 | $617.51M 10-Q · filed 2012-10-19 |
| 2012-06-30 | $589.93M 10-Q · filed 2012-07-20 |
| 2012-03-31 | $566.88M 10-Q · filed 2012-04-20 |
| 2011-12-31 | $539.58M 10-K · filed 2013-02-19 |
| 2011-09-30 | $585.94M 10-Q · filed 2011-10-21 |
| 2011-06-30 | $608.77M 10-Q · filed 2011-07-22 |
| 2011-03-31 | $596.87M 10-Q · filed 2011-04-21 |
| 2010-12-31 | $574.24M 10-K · filed 2012-02-17 |
| 2010-09-30 | $546.61M 10-Q · filed 2010-10-22 |
| 2010-06-30 | $524.26M 10-Q · filed 2010-07-23 |
| 2009-12-31 | $514.57M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |